Delivery Order SPE2DB22D3009-SPE2DB24FAW18
Award Date
5/10/24
Potential Completion Date
6/3/24
Potential Value
$5.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $2,910.65 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The delivery order is for 200-unit vials of BOTOX. This order is part of Amerisourcebergen's larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The IDC does not...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract valued at $13,971.12 to Amerisourcebergen Drug Corp for the supply of 200 unit vials of BOTOX. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999, for the provision of a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The...
The U.S. Defense Logistics Agency (DLA) awarded a $11,642.60 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 200-unit vials of BOTOX. The contract has an ultimate completion date of September 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a $2,910.65 Firm Fixed Price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 200-unit vials of BOTOX. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between DLA Troop Support Medical and Amerisourcebergen, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
The Defense Logistics Agency (DLA) awarded a $1,164.26 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 200-unit vials of BOTOX. This contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical supplies to...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,719,032 units of BOTOX 200 unit vials. The $13,971.12 contract has a completion date of March 12, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and is known to hold an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a wide range of...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,985.56 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 200-unit vials of the pharmaceutical product Botox. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical products and medical supplies...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of 200 unit vials of Botox. The firm-fixed-price contract is valued at $3,492.78 and has a period of performance through July 19, 2024. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive supply chain to fulfill government contracts, particularly for the Department of Defense (DoD) and Veterans Affairs (VA)...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide BOTOX 200 unit vials. The $3,492.78 order has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is a subsidiary of the larger Amerisourcebergen Corporation and serves as a prime contractor to DLA, providing a range of pharmaceutical products and medical supplies in support of military treatment...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $5,821.30 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 4,563,562,500 units of BOTOX 200 unit vials. The contract has a completion date of February 26, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA that has a potential value of $999,999,999.00 and a performance period through December...